ZINPLAVA (Bezlotoxumab)
ZINPLAVA(TM) is indicated to reduce recurrence of Clostridium difficile infection (CDI) in patients 18 years of age or older who are receiving antibacterial drug treatment of CDI and are…
Medications with Generic Name Beginning ‘B’, Page 97
Page 97 of 244 « First Page « … 5 10 15 20 25 … 95 96 97 98 99 … 105 110 115 120 125 … » Last Page »
Bicalutamide
Bicalutamide Tablets. USP 50 mg daily are indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. Bicalutamide Tablets. USP 150 mg daily…
Bicalutamide
Bicalutamide 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. Bicalutamide 150 mg daily is not approved for use…
Bicalutamide
Bicalutamide Tablets. USP 50 mg daily are indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. Bicalutamide Tablets. USP 150 mg daily…
CASODEX (Bicalutamide)
CASODEX 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. CASODEX 150 mg daily is not approved for use alone or…